|
Advertisement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J. Biol. Chem., Vol. 277, Issue 31, 27725-27732, August 2, 2002
From the
Received for publication, April 9, 2002, and in revised form, May 15, 2002
Cytochromes P450 are members of a
superfamily of hemoproteins involved in the oxidative metabolism of
various physiologic and xenobiotic compounds in eukaryotes and
prokaryotes. Studies on bacterial P450s, particularly those involved in
monoterpene oxidation, have provided an integral contribution to our
understanding of these proteins, away from the problems encountered
with eukaryotic forms. We report here a novel cytochrome P450
(P450cin, CYP176A1) purified from a strain of
Citrobacter braakii that is capable of using cineole 1 as
its sole source of carbon and energy. This enzyme has been purified to
homogeneity and the amino acid sequences of three tryptic peptides
determined. By using this information, a PCR-based cloning strategy was
developed that allowed the isolation of a 4-kb DNA fragment containing
the cytochrome P450cin gene (cinA). Sequencing
revealed three open reading frames that were identified on the basis of
sequence homology as a cytochrome P450, an NADPH-dependent
flavodoxin/ferrodoxin reductase, and a flavodoxin. This arrangement
suggests that P450cin may be the first isolated P450 to use
a flavodoxin as its natural redox partner. Sequencing also identified
the unprecedented substitution of a highly conserved, catalytically
important active site threonine with an asparagine residue. The P450
gene was subcloned and heterologously expressed in Escherichia
coli at ~2000 nmol/liter of original culture, and purification
was achieved by standard protocols. Postulating the native E. coli flavodoxin/flavodoxin reductase system might mimic the
natural redox partners of P450cin, it was expressed in
E. coli in the presence of cineole 1. A product was formed
in vivo that was tentatively identified by gas
chromatography-mass spectrometry as 2-hydroxycineole 2. Examination of
P450cin by UV-visible spectroscopy revealed typical spectra
characteristic of P450s, a high affinity for cineole 1 (KD = 0.7 µM), and a large spin state
change of the heme iron associated with binding of cineole 1. These
facts support the hypothesis that cineole 1 is the natural substrate for this enzyme and that P450cin catalyzes the initial
monooxygenation of cineole 1 biodegradation. This constitutes the first
characterization of an enzyme involved in this pathway.
The cytochrome P450s
(P450s)1 are a superfamily of
oxidative hemoproteins (1, 2) that carry out an enormous variety of oxidative transformations. These range from simple alkene epoxidation and heteroatom oxidation all the way through oxygen insertion into
unactivated C-H bonds and C-C bond cleavage (3). P450s are broadly
categorized as either soluble, e.g. most bacterial P450s, or
as membrane bound/microsomal monooxygenases, e.g. most eukaryotic P450s. All P450s, however, contain a prosthetic heme group
that is ligated to the protein backbone by a cysteinyl sulfur coordinated to the heme iron. It is this heme-thiolate moiety that is
responsible for much of the chemistry carried out by these enzymes. The
typical reaction catalyzed by a P450 is given by Reaction 1,
The exact mechanism of the oxidation reaction is still the
subject of much debate, despite an enormous amount of work (3, 4). The
electrons derived from the nicotinamide cofactors are generally
transferred to the P450 one at a time by auxiliary redox protein(s)
that are characteristic of the origin of the enzymes. Thus, bacterial
P450s generally employ an FAD-dependent ferrodoxin reductase and an iron-sulfur protein to mediate this transfer, whereas
microsomal P450s employ a single protein that contains both an FAD and
an FMN domain.
Investigations of bacterial P450s have provided much of our current
understanding of P450 mechanism and structure. This is particularly
true of P450cam isolated from Pseudomonas
putida, in part because it was the first P450 available in
relatively large amounts (5). However, some features of
P450cam appear to be unique to this enzyme, e.g.
a potassium-binding site (6), and not typical of this enzyme class.
P450cam still remains the most studied of all P450s and one
of the few bacterial enzymes of this family that has been
heterologously expressed with its redox partners as a catalytically
active system (7). It is a biodegradative enzyme that catalyzes the
conversion of camphor to 5-exo-hydroxycamphor, which
initiates a cascade of biodegradative reactions that allow P. putida to live on camphor as its sole source of carbon and energy
(8). P450cam and others involved in such pathways,
e.g. P450lin (9) and P450terp (10),
are generally characterized by high substrate specificity and high rates of turnover. As such, they make attractive starting points for
attempting to design biocatalysts that can carry out synthetically useful oxidative transformations. We wished to isolate a new bacterial biodegradative P450 system that could be (i) used for comparison with
P450cam, (ii) heterologously expressed as a catalytically active system, and (iii) used as the basis for constructing libraries of P450s that would be explored for their ability to catalyze useful
oxidative transformations. Such a P450 system was implicated in the
bacterial utilization of 1,8-cineole (cineole, 1, Scheme
1).
Eucalypt trees produce a mixture of nearly 50 hydrocarbons termed the "essential oil" which contains extremely high concentrations of the monoterpene cineole 1. The role of cineole 1 is somewhat unclear, although it is believed to be involved in a number of functions including defense against herbivores (11, 12) and pathogens (13), attracting pollinators and fruit-dispersing animals (14), and/or as an allelopathic agent (15, 16). The Australian eucalypt population collectively produces and releases an estimated 500,000 tons of cineole 1 into the environment annually (17). Studies indicate that the major part of the released cineole 1 is rapidly removed by microbial oxidation (18), with lesser quantities consumed by native wildlife (19) and bushfires. In 1979 MacRae et al. (18) isolated a soil microorganism identified as Pseudomonas flava, which could utilize cineole 1 as it sole source of carbon and energy, and oxidized derivatives of cineole 1 were identified in the growth medium. Subsequently, Trudgill and co-workers (20) identified a Rhodococcus species also capable of using cineole 1 as its sole carbon source and similarly identified oxygenated cineole derivatives. Interestingly, it was found that the initial oxidation of cineole 1 by the two organisms produced enantiomeric forms of 2-hydroxycineole 2. A metabolic pathway for the catabolism of cineole 1 in Rhodococcus sp. C1 was proposed, based on the isolated metabolites (Scheme 1). Thus, cineole 1 is initially oxidized to 2-hydroxycineole 2 by a monooxygenase, and further transformations lead to a highly functionalized hydroxyketo acid 3 that may spontaneously form the isolated dihydrofuranone 4 or be incorporated into central metabolic pathways. Despite the relatively large amount of information concerning the chemistry of the cineole 1 biodegradative pathway, nothing was known about the enzymes involved. Early attempts at isolating the proposed monooxygenase that catalyzes cineole 1 oxidation failed (21). Several lines of evidence suggested, however, that the monooxygenase might be a P450. The biodegradative utilization's of a number of monoterpenes, including camphor, linalool, and terpineol, have all been shown to be initiated by oxidations catalyzed by P450s (21). Additionally, CYP3A4 was recently identified as being the main P450 isoform responsible for cineole 1 metabolism in humans, with the primary product, 2-hydroxycineole 2, being the same as the one implicated in bacterial biodegradation (22). Finally, the relative scarcity of other enzymes, e.g. non-heme iron oxygenases capable of carrying out such an oxidation, also suggested a P450 would be involved. We thus set out to isolate and characterize a monooxygenase system
involved in the bacterial utilization of cineole 1. Reported
here is the isolation, overexpression, and purification of a P450,
P450cin, believed to be responsible for cineole
1 oxidation. In addition, the sequences of two genes that
may encode the required redox partners for P450cin are
described along with preliminary characterization of the P450 that
supports its involvement in the biodegradation of cineole
1.
Materials--
Yeast extract and Bacto-tryptone were obtained
from BD PharMingen. Reagent grade 1,8-cineole was obtained from
Aldrich. Sodium dithionite (sodium hydrosulfite) was purchased from
Aldrich. Nylon hybridization transfer membranes (GeneScreen Plus) were
obtained from PerkinElmer Life Sciences. All other chemicals used were purchased from commercial sources and were of the highest grade generally available. The restriction enzymes and polynucleotide kinase
were obtained from New England Biolabs, Inc. (Beverly, MA), and Roche
Molecular Biochemicals based on availability. Terminal deoxynucleotidyltransferase was obtained from Promega Corp. (Madison, WI). Escherichia coli strain, DH5 Isolation of the Microorganism-- Soil samples were collected from several sites beneath eucalypt trees within a small eucalypt forest at the University of California, San Francisco. A dirt/water slurry prepared from each sample was transferred to minimal medium (23), and bacteria were selected for the ability to use 1,8-cineole as the sole carbon source. Following several rounds of serial culturing (1:50 dilutions) at 30 °C, the cell culture was spread onto minimal medium plates (1.5% agar plates) with 0.5 g of cineole in the lid, yielding a single pure strain according to the protocol of Peterson and Lu (23). The strain was propagated in 10-15 ml of minimal medium with 20 µl of 1,8-cineole at 30 °C. Tryptic Digest of P450cin-- Internal amino acid sequence for P450cin was obtained from tryptic peptides of P450cin. These were purified by microbore high pressure liquid chromatography and sequenced using automated Edman degradation protein sequencer. These data were used in concert with that obtained via matrix-assisted laser desorption ionization-mass spectrometry to yield the sequence of three fragments (Table I). Preparation of Whole Cell DNA-- Cells were grown on minimal medium (23) with 1,8-cineole as the sole carbon source at 30 °C. Whole cell DNA was prepared according to Peterson et al. (24). Generation of an Oligonucleotide Probe to Cytochrome
P450cin--
A 92-bp PCR product was amplified from whole
cell DNA (Citrobacter braakii) using degenerate
primers2 (5'-ATAT GAATTC TGG
GCN ATM CAN CAH GT-3' and 5'-TATC
GGATCC CK NGC RTG NGC
NAC-3') designed based upon five amino acids at either end
of fragment 1 (Fig. 1). PCR was performed according to the following
protocol: 94 °C for 3 min (94 °C for 1 min, ramp to 37 °C over
2 min, 72 °C for 1 min) for 5 cycles; (94 °C for 1 min, 55 °C
for 1 min, 72 °C for 1 min) for 25 cycles; 72 °C for 10 min;
4 °C. The product was treated with BamHI and
EcoRI and cloned into similarly cut pCRIITM (Invitrogen).
The insert was sequenced on an automated sequencer using M13 forward
and reverse primers, confirming the central non-degenerate 42 bp coded
for the same 14 amino acids seen in fragment 1 (Table I). The 92-bp
insert was labeled with [ Library Construction and Screening-- DNA isolated from C. braakii was digested with a bank of restriction enzymes (KpnI, PstI, SalI, PstI/HindIII, SalI/HindIII, and XhoI) and separated by electrophoresis on an agarose gel (0.7% w/v, 0.5× TBE). The DNA was transferred to a nylon membrane (GeneScreen Plus PerkinElmer Life Sciences) by capillary transfer, dried, and probed with labeled oligonucleotide (26). Autoradiography revealed bands of suitable size in PstI (4 kb) and SalI (3 kb) digests. These latter digests were repeated, separated by electrophoresis, and the bands of appropriate size recovered by gel extraction.
The recovered DNA fragments were ligated into PstI- or
SalI-digested pUC19 and transformed individually into
library efficiency DH5 Sequencing-- Careful restriction analysis of clones pC1 and pC4 identified a series of small internal fragments that were subcloned and sequenced using the M13 forward and reverse primers. Gaps remaining in the sequence were filled by employing suitable synthetic primers. Sequencing data were analyzed using the BLAST algorithm (NCBI Database), and three open reading frames (cinA, cinB, and cinC) were identified which were sequenced completely in both directions. Cloning of P450cin-- Primers were designed to either end of cinA containing suitable terminal restriction sites (EcoRI and NdeI for the N-terminal primer 5'-CC GATTC CATATG AC TGC GAC AGT CGC-3' and XbaI and EcoRI for the C-terminal primer 5'-CC GAATTCTAGA GGA GCT TGC TCA TTC CG-3'). A PCR experiment was performed with pC1 as template DNA according to the following parameters: 94 °C for 3 min; 30 cycles of 94 °C for 45 s, 52 °C for 1 min, 72 °C for 1 min 30 s. The single 1.2-kb product was digested with EcoRI and inserted into the EcoRI site of pUCPKS (28). To ensure no errors had been introduced by PCR the majority of the internal sequence was replaced according to the following procedure: the clone was cut with NcoI, treated with DNA polymerase (Klenow) in a fill-in reaction, and religated to produce a selectable P450cin mutant. Both the mutant and pC1 were digested with PpuMI/SphI. The wild-type 1.2-kb PpuMI/SphI insert from pC1 was used to replace the mutant insert in pUCPKS. An NcoI digest was performed to confirm the wild-type fragment had indeed been inserted, and sequencing (using M13 forward and reverse primers) confirmed no PCR errors were incorporated into either terminus of cinA. An EcoRI fragment was excised from pUCPKS-cinA and cloned into pUC19. This allowed convenient excision with NdeI/HindIII for insertion into pCW, producing pCW-P450cin. Purification of Recombinant Cytochrome
P450cin--
E. coli (DH5 Calculation of Molar Extinction Coefficients ( In Vivo Oxidation of Cineole by
P450cin--
E. coli (DH5
Isolation of C. braakii-- A microorganism capable of utilizing 1,8-cineole 1 as its sole carbon source was isolated through culture enrichment (23) of bacteria from the cineole 1-enriched soils beneath eucalypt trees. The procedure yielded a pure strain identified using the Biolog Identification System (Biolog, Inc., Hayward, CA) (30) as C. braakii. This strain grew best at room temperature on a variety of nutrient-rich media. However, use of such media resulted in loss of the ability to grow on cineole 1 as a sole carbon source, and thus the organism was generally maintained on minimal medium (23) in the presence of cineole 1. Examination of CO difference spectra of cell lysates from these cultures indicated that a P450 was present, albeit at low concentrations. Purification of P450cin from C. braakii-- A P450 was purified from a large scale culture of C. braakii grown on minimal medium in the presence of cineole 1. The purification protocol used was based on those published for P450cam, P450terp, and P450BioI ((9, 10, 31)). A refined version of this protocol is currently used for purification of recombinant P450cin (see below). The procedure yielded purified protein with a peak fraction possessing an RZ (A415/A280) of ~1.28. The protein isolated was clearly a P450 by CO difference spectroscopy and had a molecular mass of ~45 kDa by SDS-PAGE analysis. Importantly, the heme Soret absorbance at 415 nm shifted to 392 nm in the presence of cineole 1. This is characteristic of the spin state change of the heme iron (low to high spin) seen upon binding of substrate to a P450 and strongly suggested that the isolated P450cin was involved in cineole 1 metabolism. Tryptic Digestion and Sequencing of Protein Fragments-- N-terminal sequencing of P450cin (purified from C. braakii) using automated Edman degradation failed to produce useful data, presumably due to N-terminal blocking. However, tryptic digestion of the protein followed by high pressure liquid chromatography purification of the resultant fragments gave several peptides amenable to Edman degradation. A combination of automated Edman degradation sequencing and mass spectrometry yielded the sequences of three fragments that are shown in Table I. Fragments 1 and 2 are clearly related, differing only in the identity of the first amino acid. However, as their sequences were independently obtained, we were confident of their reliability, and this sequence was chosen as the basis upon which to design oligonucleotides for use in isolation of the gene encoding P450cin. Fragment 3 was not useful for probe design due to the preponderance of amino acids with highly degenerate codons. We chose to amplify a larger segment of the P450 gene by PCR in order to generate a better probe, rather than simply employ short degenerate oligonucleotides. Thus, degenerate primers were designed to either end of coding sequence for fragment 1 and were chosen to minimize their inherent degeneracy (Fig 1). These were used in a PCR experiment with genomic DNA from C. braakii as template. The product from this PCR was sequenced and shown to encode the peptide fragment 1, providing the key unique 92-bp probe for P450cin.
Southern Hybridization--
Probing a series of restriction enzyme
digests of C. braakii genomic DNA with the 92-bp probe
labeled with 32P by reaction with
[
Operon Analysis-- Sequencing of the above DNA fragments revealed a putative operon consisting of three open reading frames with overlapping stop and start codons (Fig. 2). All ORFs were analyzed using the BLAST algorithm (32) and the GenBankTM data base. The first ORF (cinA) encoded a 405-amino acid protein with a predicted molecular mass of 45 kDa. Homology analysis indicated that it was clearly a P450, being similar to a number of bacterial P450s (Table II), including P450cam (27% identity and 46% similarity) but different enough to be classified as the sole member of a new P450 family CYP176A1 (2). All of the peptide fragments that had been characterized from the tryptic digest of the isolated P450 were encoded by this gene.
The two other ORFs (cinB and cinC) appeared to encode the expected redox partners for a catalytically functional P450 system. The second ORF (cinB) encoded a 49-kDa, 452-amino acid protein that was apparently an NADPH-dependent ferrodoxin reductase on the basis of sequence homology (Table II). The final gene (cinC) encoded a protein (16 kDa and 155 amino acids) that was most similar to the FMN-containing domain of cytochrome P450 reductase (Table II). The participation of a dedicated flavodoxin as a P450 redox partner has not been described previously, but E. coli flavodoxin has been reported to provide an unnatural redox partner for a variety of heterologously expressed cytochromes (33). Subcloning and Expression of P450cin-- A PCR-based approach was used to clone the cinA gene into the expression vector pCWori (34). Expression of the encoded protein after induction with IPTG was monitored by SDS-PAGE and CO difference spectroscopy of cell lysates. It was found that although polypeptide production occurred at temperatures from 25 to 37 °C, P450 holoprotein was only observed when the growth temperature was below 28 °C. CO difference spectroscopy indicated that P450 was produced at concentrations of ~2000 nmol/liter of original culture. Characterization of the purified protein by N-terminal sequencing and electrospray mass spectrometry gave similar results. Both techniques clearly identified the protein as P450cin and indicated that some degree of N-terminal processing of the protein had occurred. The degree of processing varied between different preparations, with some having the major species present derived from loss of the N-terminal methionine, whereas others had the predominant protein derived from loss of the first six amino acids of the predicted sequence. In Vivo Oxidation of Cineole by P450cin-- When P450cin was expressed in E. coli in the presence of cineole 1, a metabolite was produced with mass spectral characteristics consistent with that of 2-hydroxycineole 2. This compound was not produced when E. coli not expressing P450cin was grown in the presence of cineole 1. This result strongly supports the hypothesis that P450cin catalyzes the first monooxygenation in the biodegradation of cineole 1. Spectral Characteristics of Cytochrome
P450cin--
The protein was first examined by UV-visible
spectroscopy (Fig. 3) that revealed the
typical characteristics of a bacterial P450, a heme Soret at 415 nm in
the absence of substrate which shifted to 392 nm upon the addition of
cineole 1. This spectral change is correlated with a change
in the heme iron from low to high spin and is associated with the
binding of substrate to bacterial P450s and as such was the first
evidence that cineole 1 was indeed the natural substrate of
this enzyme. Reduction of the protein with dithionite and treatment
with CO resulted in the formation of a CO complex with the typical 449 nm absorbance of a P450.
1,8-Cineole Binding by Cytochrome P450cin--
The
addition of 1,8-cineole 1 to the substrate-free form of the
enzyme results in a decrease in absorbance at 415 and 568 nm and an
increase in absorbance at 392 and 643 nm, indicating the conversion of
low spin hemoprotein to the high spin form (35). Difference
spectroscopy (Fig. 4) was used to
calculate a dissociation constant for the enzyme-substrate complex
(KD) by adding cineole 1 to a solution of
P450cin and monitoring the absorbance at 415 and 392 nm.
The difference (measured as
A392-A415) was plotted
against the cineole 1 concentration to produce a
substrate-binding curve (Fig. 4) from which a KD
value of 0.7 µM was determined using Equation 1,
A is the measured peak to trough difference in
absorbance between 415 and 392 nm; Amax is
the maximal A value; and is the molar absorptivity
constant for the difference in absorbance at 415 and 392 nm of the high
(HS) and low spin (LS) forms of the P450, i.e.
(( 415LS 415HS) + ( 392HS 392LS)). This calculation was made with the following assumptions: 1) [S]TOT = [S]FREE + [ES]; and 2)
[E]TOT = [E]FREE + [ES], where [ES] is the concentration of the
P450-ligand complex; [S]TOT and [S]FREE are
the total and free ligand concentration, respectively; and
[E]TOT and [E]FREE are the total and free P450 concentration, respectively. Because of the
high affinity of the enzyme for its ligand, the assumption that
[ES] [S]TOT, which would greatly
simplify the calculation, is not valid.
Prior to the beginning of this work, much was known about the chemistry of cineole 1 biodegradation. Two organisms had been independently isolated previously that could live on cineole 1 as their sole source of carbon and energy (18, 20). From an investigation of the oxidized cineole metabolites isolated from growth media, a consensus biodegradative pathway was proposed (Scheme 1), albeit proceeding via intermediates with different absolute stereochemistry in each of the two organisms. Nothing was known about the enzymes involved in the proposed pathway, despite some early investigations (21). Our results support the hypothesis that a P450 is responsible for the initial step in the biodegradation of cineole 1. We isolated from the soil of a eucalypt forest a strain of C. braakii that could utilize cineole 1 for growth and energy. C. braakii is a Gram-negative motile rod that is a common environmental organism and that has recently been reclassified from Citrobacter freundii (36). P. flava and Rhodococcus, in which cineole 1 utilization had been found previously, are also common Gram-negative organisms. Given the quantity of cineole 1 that is believed to be released into the environment by eucalypts, we were not surprised to find that a third genus of bacteria has developed the ability to grow on this compound. The organism grew poorly on minimal medium in our hands when cultured on a large scale, and although it grew well on nutrient rich-media, such growth resulted in loss of its ability to utilize cineole 1. This latter fact perhaps suggests that the genes responsible for cineole 1 metabolism are plasmid-borne as has been shown for the P450s involved in camphor and terpineol utilization (10, 37). The difficulty in growing the organism clearly meant that isolation of the gene encoding the cineole monooxygenase would be essential for its characterization. Initial approaches to isolating the P450 gene focused on its expected homology with other P450s, because this seemed to offer the most direct route to P450cin. Homology-based methodology in bacterial P450 systems is particularly difficult, however, because most of these proteins reside in sparsely populated families with only limited regional homology to one another. However, with this in mind, a degenerate oligonucleotide was constructed based upon the conserved region that includes the cysteine that ligates the heme iron and used to probe genomic DNA from C. braakii. A second protocol used this oligonucleotide in a genomic PCR with another degenerate primer based upon a conserved region seen in the redoxin reductase partners of P450cam and P450terp. The latter experiment was based on the hypothesis that the P450cin gene would be followed directly by those of its redox partners and that the first of these would encode a redoxin reductase as seen in the P450cam and P450terp operons. Both approaches were unsuccessful, due in part to the limited sensitivity of the degenerate oligonucleotides. In addition, although the architecture of the P450cin operon was as expected, the proteins encoded constitute an entirely novel redox system for P450s with no homology to those found with other bacterial P450s. More protein-specific information was thus required, and this was
obtained by isolating native P450cin from C. braakii. Protein purification proved remarkably straightforward,
with essentially homogenous protein obtained in three steps using a
protocol based upon that published for P450cam and
P450BioI. Protein sequence, obtained via trypsinolysis and
peptide sequencing, was used to design degenerate PCR primers to either
end of a large peptide fragment (Fig. 1). A 92-bp oligonucleotide probe
for P450cin was then generated via genomic PCR. This
oligonucleotide was labeled with 32P by reaction with
[ Sequencing of the isolated DNA revealed a putative P450cin
operon that contained three open reading frames with overlapping start
and stop codons (Fig. 2). The first of these genes clearly encoded a
P450, as seen by its strong similarity to a number of other bacterial
P450s (Table II). The encoded protein was classified as CYP176A1 and
trivially denoted as P450cin. Although most of the
conserved residues found in P450s were also seen in
P450cin, there was one striking exception (Fig.
5). Threonine 252 in P450cam is located on the I helix, a conserved structural feature of P450s, and
is believed to hydrogen-bond to a water molecule during the oxygen
activation process and thus direct delivery of a proton to the distal
oxygen in the iron-dioxygen complex (38, 39). This specific delivery is
believed to result in cleavage of the O-O bond to yield the active
ferryl species; delivery of a proton to the proximal oxygen is thought
to result in the dissociation of hydrogen peroxide (so-called
uncoupling). Given the essential role of this residue in catalysis it
is not surprising that a threonine or serine is seen in this
position in essentially all known P450s. An exception occurs in
P450eryF (CYP107A1), in which it is replaced by an alanine; in this
enzyme a hydroxyl group located on the substrate is believed
responsible for the positioning of the required water molecule. In
P450cin, however, sequence alignments suggest that the
threonine has been replaced with an asparagine. Clearly, the amide
functionality of the asparagine could serve to hydrogen-bond to a water
molecule and thus direct proton delivery and cleavage of the dioxygen
bond. However, this would be the first time that a hydroxyl group has
not filled this role, and further experimentation will be required to
validate this hypothesis.
The two further genes discovered during the sequencing of the putative operon appear to encode potential redox partners for P450cin. Although this arrangement is identical to that seen in the P450cam and P450terp operons, the identity of these redox partners is quite different. In general there are two types of P450, as classified by their auxiliary electron transport partners. In bacteria and mitochondria (class I P450s) there are two proteins that mediate the transfer of electrons from the pyridine nucleotide to the P450; one is an FAD-containing ferrodoxin reductase, and the other is an iron-sulfur protein, either 2Fe-2S or 3Fe-4S. In eukaryotes (class II P450s), there is generally a single flavoprotein, cytochrome P450 reductase that contains both an FAD and an FMN cofactor, which mediates P450 reduction. Other less common arrangements also exist for electron transfer. P450nor (40) accepts electrons directly from NADH, whereas P450BM-3 (41), a bacterial P450, incorporates both a class II-like reductase and a P450 domain into a single polypeptide. Class III P450s, e.g. CYP74A, do not require exogenous redox partners because they act upon peroxide-containing substrates (42-44). Analysis of the second gene in the P450cin operon revealed that it had strong homology with adrenoredoxin reductase, the ferrodoxin reductase that functions in the adrenal mitochondrial system (Table II). However, the third gene of the operon appeared to be a flavodoxin and not an iron-sulfur-containing protein, because a BLAST search indicated that it was most homologous to the FMN domain of CPR (Table II). This suggests that P450cin utilizes a novel, natural redox system for electron transfer, which consists of an FAD-dependent flavodoxin reductase and an FMN-containing flavodoxin. This system is intermediate between the classical class I bacterial P450 that utilizes two proteins, but which includes one with an Fe-S cluster, and the class II P450 that only employs a single protein but utilizes FAD and FMN cofactors. Although there is no precedent for this type of system occurring naturally, it has been reported that flavodoxins can act as "unnatural" redox partners for P450s. Waterman and co-workers (33, 45) have shown that the flavodoxin reductase and flavodoxin systems from both E. coli and Anabaena will serve as functional redox partners for a variety of (heterologous) mitochondrial P450s. It should be noted that there is as yet no firm experimental evidence that links P450cin with the two proteins as its redox partners. However, as mentioned, the arrangement of the genes within the operon is identical to that seen with both P450cam and P450terp and their redox partners. It is interesting to note that although the biodegradative P450s such as P450cam, P450terp, and P450cin occur in an operon closely associated with their redox partners, this is not the case for many other bacterial P450s uncovered by genome sequencing projects. For example, in Mycobacterium tuberculosis of the ~20 P450s identified, at least 14 have no obvious operon-associated redox partners. Perhaps this implies that biodegradative P450s are necessarily organized into operons with their electron transfer proteins to ensure coordinated expression and efficient functioning. Other bacterial P450s, which may not be required to operate as efficiently as biodegradative ones that supply the cell carbon and energy, may employ general redox partners such as cellular flavodoxins or ferrodoxins. P450cin was heterologously expressed in E. coli at a level of ~2000 nmol/liter of culture. Purification, including a hydroxyapatite column (46) as a final polishing step, gave essentially a homogeneous protein (~1000 nmol/liter) after three steps. Its identity was confirmed by N-terminal sequencing and electrospray mass spectrometry, which also indicated that some N-terminal processing (truncation of up to six amino acids) had occurred in a batch-dependent manner. However, spectral analysis of the protein (see below) revealed no effect of this inhomogeneity of the protein. Although the catalytic activity remains to be explored, it is not expected that this variation will significantly alter its efficiency, given that the N terminus is not implicated in either the mechanism of oxygen activation or the interaction with redox partners in any other bacterial P450 (47). We postulated that as P450cin was believed to have a flavodoxin as a redox partner, it might utilize the endogenous E. coli flavodoxin/flavodoxin reductase system. Waterman and co-workers (33, 45) had reported that this system was responsible for the observed catalytic activity in a variety of heterologously expressed P450s. Thus, we expressed P450cin in the presence of cineole 1, and careful gas chromatography-mass spectrometry analysis of the organic extracts of the growth medium revealed the presence of a metabolite tentatively identified as 2-hydroxycineole 2. This compound was not produced when cineole 1 was added to the growth medium of E. coli not expressing P450cin. While not conclusive, this result clearly demonstrates that P450cin is capable of cineole 1 hydroxylation and strongly suggests that it is involved in its biodegradation. UV-visible analysis of the heterologously expressed P450cin revealed the typical characteristics of a bacterial P450 (Fig. 3). Significantly, a spin state change of the heme iron from low spin to high spin was observed in the presence of cineole 1, typical of a bacterial P450 in the presence of its substrate. This and the tight binding of cineole 1 to P450cin (KD = 0.7 µM) strongly support our hypothesis that the natural substrate for this enzyme is cineole 1, because it mirrors exactly the behavior of other terpene-degrading P450s with their substrates, e.g. P450cam (5), P450terp (10), and P450lin (9). These observations combined with our in vivo turnover results also provide the first real evidence that a P450 is involved in the biodegradation of cineole 1. It will be of interest to determine the way in which this strong, specific binding of cineole 1 is achieved because it presents little, if any, opportunity for H-bonding. Such interactions are known to play an important role in the specific binding of other terpene substrates with their biodegradative P450 (48). The oxygen in cineole 1 is present as a ditertiary ether and, as such, is unlikely to participate in any H-bonding. It is hoped that crystallization trials currently underway may shed light on the specificity of this enzyme-substrate interaction. Conclusion--
A new bacterial P450 system has been isolated and
the P450 cloned and overexpressed. The high level of expression, as
well as the ease of purification, encourage us in the belief that this P450 may serve as a useful model for P450s in general and bacterial P450s in particular. It contains a number of unique features, such as
an unusual asparagine substitution for a catalytically essential
threonine, which should help to increase our fundamental understanding
of P450 mechanism. In addition, it appears that P450cin is
the first known P450 to utilize a flavodoxin as its natural redox
partner. Experiments designed to explore further the catalytic activity
and the interactions of P450cin with both its substrate and
redox partners are currently in progress.
* This work was supported in part by Australian Research Council Grants ARCS217G and DP0210635 and National Institutes of Health Grant 01614.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Dept. of Chemistry, University of Queensland, St. Lucia, Queensland 4067, Australia. Tel.: 61-7-3365-3825; Fax: 61-7-3365-4299; E-mail: devoss@chemistry.uq. edu.au.
Published, JBC Papers in Press, May 16, 2002, DOI 10.1074/jbc.M203382200
2 The Degenerate DNA code used is as follows: R = A or G; K = G or T; H = A, C, or T; M = A or C; N = A, T, C, or G.
The abbreviations used are:
P450, cytochrome
P450;
CPR, cytochrome P450 reductase;
P450cin, CYP176A1;
P450cam, CYP101;
P450terp, CYP108;
P450BioI, CYP107H;
RZ, (A415nm/A280nm) used when
determining the purity of P450 samples (> is better);
orf, open
reading frame;
IPTG, isopropyl-
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc. This article has been cited by other articles:
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||